No CrossRef data available.
Published online by Cambridge University Press: 22 September 2017
1. Smith, ME, Farah, MJ. Are prescription stimulants ‘smart pills’? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychology Bulletin 2011;137:717–41.CrossRefGoogle Scholar
2. Repantis, D, Schlattmann, P, Laisney, O, Heuser, I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacology Research 2010;62:187–206.CrossRefGoogle ScholarPubMed
3. Finke, K, Dodds, CM, Bublak, P, Regenthal, R, Baumann, F, Manly, T, et al. Effects of modafinil and methylphenidate on visual attention capacity: A TVA-based study. Psychopharmacology (Berlin) 2010;210:317–29.CrossRefGoogle ScholarPubMed
4. de Jongh, R, Bolt, I, Schermer, M, Olivier, B. Botox for the brain: Enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience and Biobehavioral Reviews 2008;32:760–76.CrossRefGoogle Scholar
5. Franke, AG, Gränsmark, P, Agricola, A, Schühle, K, Rommel, T, Sebastian, A, et al. Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial. European Neuropsychopharmacology 2017;27:248–60.CrossRefGoogle ScholarPubMed
6. See note 4, de Jongh et al. 2008.
7. Outram, SM. The use of methylphenidate among students: The future of enhancement? Journal of Medical Ethics 2010;36:198–202.CrossRefGoogle Scholar
8. Luchtman, DW, Song, C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies. Neuropharmacology 2013;64:550–65.CrossRefGoogle ScholarPubMed
9. Comite Consultatif National d’Ethique, 2013; available at http://www.ccne-ethique.fr/fr/publications/recours-aux-techniques-biomedicales-en-vue-de-neuro-amelioration-chez-la-personne-non#.WJZMIBApquU